|Role of the Board and Board Committees|FY23 Highlights| |---|---| |Ramsay Health Care Board Oversees our approach, including considering the social and environmental impact of Ramsay's activities, approving the Ramsay Cares sustainability strategy and key policies and disclosures.|• Monitored safety, patient experience and clinical quality outcomes. • Focused on our people and organisational culture, and oversight of strategic responses to workforce challenges. • Received updates on progress against sustainability linked loan targets. • Oversaw ongoing digital and data transformation to enhance patient experience, particularly in Australia. • Approved new or updated governance policies including Ramsay's: - Code of Conduct, which sets out clear expectations to ensure we all know the right way to behave, respond, take action and do our work - Global Responsible Sourcing Policy, which sets out the behaviour and standards expected of suppliers - Global Diversity & Inclusion Policy, which outlines our vision for diversity and related commitments.| |Global Risk Management Committee (GRMC) Oversees sustainability and any material social and environmental risks, including climate risks and opportunities.|• Monitored key ESG risks (including climate change, modern slavery and other sustainability risks) and frameworks. • Received deep dive updates on approach to clinical governance across the Group. • Endorsed for Board approval: - updates to the Global Sustainability Policy - a new Global Responsible Sourcing Policy. • Oversaw the ongoing implementation of our global responsible sourcing framework and key issues, including sourcing of solar panels.| |People and Remuneration Committee Oversees non-financial performance (including patient, people, customer and environmental) in-so-far as it relates to the Committee's people and remuneration responsibilities.|• Focused on people, engagement and culture, and supported the Board in overseeing strategic responses to workforce challenges. • Endorsed for Board approval our new Code of Conduct and updated Diversity & Inclusion Policy. • Received updates on non-financial performance (including patient, people, customer and environmental) for FY23, including in relation to the greenhouse intensity reduction target including in the short-term incentive (STI) scorecard of the MD & CEO and other members of the Executive team.| |Audit Committee Oversees sustainability issues as they relate to financial matters e.g. financial reporting and financing activities, opportunities and risks.|• Reviewed updates on progress against our sustainability linked loan targets. • Reviewed approach to sustainability reporting having regard to evolving requirements, including hearing from external subject matter experts. • Oversight of Internal Audit including approval of an Internal Audit Plan for FY24 that includes assurance activities related to the net zero plan – Scope 1 and 2.|